UNSPSC 51101936: Sitamaquine

This classification denotes an antiprotozoal agent with the molecular formula C21H33N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5AIJ4TGC6B, chemically known as 1,6-hexanediamine, n,n-diethyl-n-(6-methoxy-4-methyl-8-quinolinyl)- but generally known as sitamaquine, which bears US NIH Compound Identifier 42548. European Medicines Agency schedules Sitamaquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB37607.

UNSPSC 51101936 Sitamaquine is a Commodity code, but the recent state and local opportunities tagged under it reflect pharmaceutical procurement more broadly — specifically antimicrobial tablets, naloxone, and drug deactivation systems — rather than sitamaquine (an antimalarial agent) as a discrete product line. State and local health departments and county health agencies are the primary issuing bodies, using cooperative purchasing vehicles such as MMCAP Infuse consortiums alongside direct competitive bidding to source pharmaceutical inventory and emergency medical supplies. The work involves warehouse-scale pharmaceutical supply agreements with defined package counts, expiration windows, and quarterly or as-needed delivery schedules to county health buildings or public health stockpiles.

The recent activity concentrates in Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with two renewal years, valued at $2,999,999.11 total; the award closed before response deadline. Seminole County, Florida released an IFB (60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year initial term with one-year renewal option; vendors must absorb shipping and delivery costs and comply with E-Verify and drug-free workplace certification. The code shows limited recent activity and an imprecise match between the code's nominal scope and the actual pharmaceutical products being procured.